kup.at参考文章(34)
MR Kraus, A Schäfer, M Scheurlen, None, Paroxetine for the prevention of depression induced by interferon alfa. The New England Journal of Medicine. ,vol. 345, pp. 375- ,(2001)
Dienstag Jl, Davis Gl, Balart La, Perrillo Rp, Bodenheimer Hc, Payne J, Carey W, Jacobson Im, Lindsay K, Schiff Er, Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile Clinical Therapeutics. ,vol. 16, pp. 334- 343 ,(1994)
Willis C. Maddrey, Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients. Seminars in Liver Disease. ,vol. 19, pp. 67- 75 ,(1999)
Levenson Jl, Fallon Hj, Fluoxetine treatment of depression caused by interferon-alpha. The American Journal of Gastroenterology. ,vol. 88, pp. 760- 761 ,(1993)
Martha S. Bayliss, Barbara Gandek, Kathleen M. Bungay, David Sugano, Ming-Ann Hsu, John E. Ware Jr, A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C Quality of Life Research. ,vol. 7, pp. 39- 55 ,(1998) , 10.1023/A:1008884805251
David H. Lee, Hyder Jamal, Fredric G. Regenstein, Robert P. Perrillo, Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Digestive Diseases and Sciences. ,vol. 42, pp. 186- 191 ,(1997) , 10.1023/A:1018818012378
Bénédicte Gohier, Jean-Louis Goeb, Karine Rannou-Dubas, Isabelle Fouchard, Paul Calès, Jean-Bernard Garré, Hepatitis C, alpha interferon, anxiety and depression disorders: A prospective study of 71 patients World Journal of Biological Psychiatry. ,vol. 4, pp. 115- 118 ,(2003) , 10.1080/15622970310029904
M J Alter, Epidemiology of hepatitis C Hepatology. ,vol. 26, pp. 169- 183 ,(1997) , 10.1002/HEP.510260711
Tom Wachtel, Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument Annals of Internal Medicine. ,vol. 116, pp. 129- 137 ,(1992) , 10.7326/0003-4819-116-2-129
Ondria C. Gleason, William R. Yates, M. Daniel Isbell, Michelle A. Philipsen, An open-label trial of citalopram for major depression in patients with hepatitis C. The Journal of Clinical Psychiatry. ,vol. 63, pp. 194- 198 ,(2002) , 10.4088/JCP.V63N0304